Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Wyeth and Pfizer to pay $784.6 million in False Claims Act case

Jaclyn Jaeger | May 3, 2016

Wyeth and Pfizer last week reached a $784.6 million settlement with the Department of Justice to resolve allegations that Wyeth knowingly reported to the government false and fraudulent prices on two of its drugs.

Under the terms of the settlement, Wyeth will pay $413.2 million to the federal government and $371.3 million to state Medicaid programs. Pfizer acquired Wyeth in 2009, approximately three years after Wyeth ended the conduct that gave rise to the settlement.

In a complaint filed in 2009, the government alleged that Wyeth failed to report deep discounts on two of its proton pump inhibitor (PPI) drugs—Protonix Oral and Protonix IV--that it made available to thousands of hospitals nationwide. As part of the settlement, Wyeth and Pfizer do not deny the government’s allegations.

According to the government’s complaint,...

Buy this article for $49, or subscribe to Compliance Week for a month at $149 and get unlimited article access for 30 days.